查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1189853

動脈切開術閉合裝置市場——增長、趨勢和預測 (2023-2028)

Arteriotomy Closure Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，動脈切開術閉合裝置市場的複合年增長率預計為 6.6%。

COVID-19 的爆發對市場產生了影響，因為在大流行期間血管疾病的比例顯著增加。 例如，2022 年 3 月在 WebMD 上發表的一項研究發現，感染 COVID-19 的人感染後患 20 種心臟和血管疾病的風險增加。 它還說，長期 COVID-19 患者被診斷出 20 種心髒病。 專利閉合裝置廣泛用於減少血管並發症、止血和下床時間。 因此，血管疾病的增加增加了對動脈切開術閉合裝置的需求，導致大流行期間市場顯著增長。 COVID-19 疫情對市場產生了重大影響，但預計將在大流行後恢復強勁增長。

人口老齡化加劇是推動市場增長的主要因素。 例如，根據印度國家人口委員會2021年7月發布的報告，2021年印度約有1.38億老年人，其中男性6700萬，女性7100萬，估計達數百萬。 此外，老年人口的增長速度高於一般人口，據報導，過去20年老年人口增長了36.0%。 同樣，2021 年 12 月發表的一項研究發現，在 45 歲及以上的人群中，自我報告的已確診心血管疾病 (CVD) 總體患病率為 29.4%，患病率隨年齡增長而增加。45-54 歲人群中為 22.0% 70歲及以上人群為38.0%，表明老年人患心血管疾病的風險較高，是發病率上升的主要因素。 因此，預計在預測期內將出現可觀的市場增長。

但是，設備的高成本可能會阻礙預測期內的市場增長。

主要市場趨勢

被動關閉裝置預計在預測期內增長最快

被動閉合裝置已成為介入心髒病專家和其他手術專業人員在導管插入部位實現止血的強大工具。 被動閉合裝置通過機械壓縮和增加血栓形成幫助實現有效止血。 然而，被動閉合裝置不會加速止血所需的實際時間。 被動閉合裝置通常是膠原蛋白（一種存在於皮膚、骨骼和結締組織中的纖維蛋白）、金屬夾或縫合線，旨在在血管造影後立即封閉動脈中的小穿孔。(Sucher)。

不斷上升的高血壓病例和人口老齡化是推動這一細分市場增長的主要因素。 例如，根據亞太衛生系統和政策觀察站 2021 年 11 月發布的一份報告，到 2050 年，由於該地區的生育率下降和壽命延長，亞太地區約四分之一的人口將 1 60歲以上。 預計這將進一步增加心血管疾病的負擔，並推動對有效和先進治療方式的需求。 此外，根據澳大利亞健康與福利研究所 2022 的數據，估計 571,000 名 18 歲及以上的澳大利亞人（佔成年人口的 2.9%）將在 2020 年至 2021 年期間患有心血管疾病。 這是基於澳大利亞統計局 2020-21 年全國健康調查的自我報告數據。 據說老年人更容易患心血管疾病和高血壓。 因此，預計日益增加的老齡化人口將對該細分市場產生積極影響。

此外，高血壓是導致心血管疾病的主要原因之一。 高血壓被定義為 130 毫米汞柱或更高的收縮壓或 80 毫米汞柱或更高的舒張壓。 根據美國疾病預防控制中心 2021 年發布的一份報告，美國約有 47.0% 或超過一半的成年人患有高血壓或正在服用降壓藥。 因此，預計老年人口的增加和心血管疾病負擔的增加將在預測期內推動研究領域的增長。

預計北美地區在預測期內將顯著增長

預計在預測期內，北美的整個動脈切開術閉合器械市場將出□□現顯著增長。 這種增長是由於血管疾病病例增加和老年人口增加等因素造成的。 例如，根據美國疾病控制與預防中心2021年的數據，美國每年有超過805,000人心髒病發作，其中605,000人是第一次心髒病發作，200,000人有過心髒病發作史。 同樣，美國心臟協會 2021 年雜誌估計，到 2035 年，美國將有超過 1.3 億成年人患有某種形式的心髒病。 由於心血管疾病負擔的增加，預計北美地區的市場將出現可觀的增長。

主要產品的發布、市場參與者和製造商的高度集中、主要參與者之間的收購和合作以及美國心血管疾病的增加是推動該國動脈切開術閉合裝置市場增長的一些因素。變成了一個部門。 例如，2021 年 9 月，Haemonetics Corporation 宣布 VASCADE MVP 靜脈血管閉合系統獲得 FDA 批准，用於治療房顫 (AF) 消融術後當天出院的患者。

因此，上述因素有望推動北美地區研究市場的增長。

競爭格局

動脈切開術閉合裝置市場競爭適中，由幾家大型企業組成。 從市場份額的角度來看，目前幾家大型企業佔據了市場主導地位。 競爭格局包括擁有市場份額的知名國際參與者，如雅培實驗室、Terumo Corporation、Cardinal Health (Cordis)、Cardiva Medical、Merit Medical、Medtronic PLC、Teleflex Incorporated、Vivasure Medical、OtsUnited Kingdoma Medical Devices (Veryan Medical)。包括對企業和一些本地企業的分析。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 血管疾病的發生率增加
    • 老年人口增加
  • 市場製約因素
    • 設備成本高
    • 與手術相關的風險
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模 - 百萬美元）

  • 按產品分類
    • 主動關閉裝置
    • 被動閉合裝置
  • 通過申請
    • 股動脈通路手術
    • 橈動脈通路
  • 最終用戶
    • 醫院
    • 門診中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Abbott Laboratories
    • Cardinal Health（Cordis）
    • Cardiva Medical（Haemonetics）
    • Medtronic PLC
    • Merit Medical
    • Teleflex Incorporated
    • Terumo Corporation
    • OtsUnited Kingdoma Medical Devices Co. Ltd（Veryan Medical）
    • Vivasure Medical

第7章 市場機會與今後動向

簡介目錄
Product Code: 66775

The arteriotomy closure devices market is expected to register a CAGR of 6.6% over the forecast period.

The COVID-19 outbreak impacted the market as the rate of vascular diseases significantly increased during the pandemic. For instance, as per the study published in WebMD in March 2022, people who contracted COVID-19 were at a higher risk for 20 different heart and vascular diseases after being infected. The study also stated that 20 heart disorders were diagnosed in patients who suffered from long-term COVID-19 disease. Arteriotomy closure devices are widely used to decrease vascular complications and reduce the time to hemostasis and ambulation. Therefore, increasing cases of vascular diseases indicate that there was an increased demand for arteriotomy closure devices, owing to which the market witnessed considerable growth during the pandemic. Although the COVID-19 outbreak severely impacted the market, it is expected to recover in the post-pandemic era to post-strong growth.

The rising geriatric population is the major factor driving the market's growth. For instance, as per the report published by the National Commission on Population in India in July 2021, it was estimated that around 138.0 million elderly persons were living in India in 2021, of which 67.0 million were males, and 71.0 million were females. The report also stated that the growth rate of the elderly population was higher than that of the general population, and the elderly population has grown by 36.0% in the last two decades. Similarly, according to the research study published in December 2021, the overall self-reported prevalence of diagnosed cardiovascular diseases (CVDs) was 29.4% for older persons of age 45 and over, and the prevalence rate rose with age, from 22.0% in the 45-54 age group to 38.0% in the 70+ age group which shows that the geriatric population is at high risk of having cardiovascular diseases Thus, increasing geriatric population is one of the major factors for increasing the prevalence rate of cardiovascular diseases. Therefore, considerable market growth is anticipated over the forecast period.

However, the high cost of the devices may likely hinder the market's growth over the forecast period.

Key Market Trends

Passive Closure Devices Segment is Expected to Witness the Largest Growth over the Forecast Period

Passive closure devices have become a powerful tool for interventional cardiologists and other procedural professionals to achieve hemostasis at the catheter entry site. Passive closure devices help with mechanical compression or by increasing thrombosis for effective hemostasis. However, passive devices do not hasten the actual time it takes to reach hemostasis. The passive closure device is usually a piece of collagen (a fibrous protein found in skin, bone, and connective tissue), a metal clip, or a suture (suture) designed to provide immediate sealing of a small puncture made in an artery after an angiogram.

The increasing cases of hypertension and the rising geriatric population are the major factors propelling the segment's growth. For instance, as per the November 2021 report published by the Asian Pacific Observatory on Health Systems and Policies, by 2050, about one-fourth population of the Asia-Pacific region will be 60 years or older due to the decreasing fertility rate and increasing longevity in the region. This is further expected to increase the burden of cardiovascular diseases and thus drive the demand for effective and advanced treatment procedures. Furthermore, according to the Australian Institute of Health and Welfare in 2022, during 2020-2021, an estimated 571,000 Australians aged 18 and over (2.9% of the adult population) had cardiovascular diseases. This is based on self-reported data from the Australian Bureau of Statistics 2020-21 National Health Survey. The geriatric population is more prone to cardiovascular diseases and hypertension cases. Therefore, the rising geriatric population is expected to positively impact the segment.

Furthermore, hypertension is one of the major factors contributing to cardiovascular diseases. Hypertension is defined as systolic blood pressure greater than 130 mmHg or diastolic blood pressure greater than 80 mmHg. According to the report published by CDC in 2021, around more than half of the adults in United States, which is around 47.0%, have hypertension or are taking medication for hypertension. Therefore, the increase in the geriatric population and the increasing burden of cardiovascular diseases is expected to fuel growth in the segment studied over the forecast period.

North American Region is Expected to Witness Significant Growth over the Forecast Period

North America is expected to witness significant growth in the overall arteriotomy closure devices market over the forecast period. The growth is due to factors such as the rising cases of vascular diseases and the increasing geriatric population. For instance, as per the 2021 data from the Centers for Disease Control and Prevention, every year, more than 805,000 people in United States have a heart attack; 605,000 of these result in a first-time heart attack, while 200,000 are caused by previous heart attacks. Similarly, as stated by the AHA 2021 Journal, it is estimated that by 2035, more than 130 million adults in United States will have some type of heart disease. With this increasing burden of cardiovascular diseases, the market is anticipated to witness considerable growth in the North American region.

Key product launches, high concentration of market players or manufacturers' presence, acquisitions, and partnerships among major players, and rising cardiovascular diseases in United States are some of the factors driving the growth of the arteriotomy closure devices market in the country. For instance, in September 2021, Haemonetics Corporation announced that the VASCADE MVP Venous Vascular Closure System had received FDA approval for treating patients having same-day discharge following atrial fibrillation (AF) ablation.

Therefore, owing to the aforementioned factors, the growth of the market studied is anticipated in the North American Region.

Competitive Landscape

The arteriotomy closure devices market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. The competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known, including Abbott Laboratories, Terumo Corporation, Cardinal Health (Cordis), Cardiva Medical, Merit Medical, Medtronic PLC, Teleflex Incorporated, Vivasure Medical, and Otsuka Medical Devices Co. Ltd (Veryan Medical), among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidences of Vascular Disorders
    • 4.2.2 Rising Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Device
    • 4.3.2 Risk Associated With the Procedure
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Active Closure Devices
    • 5.1.2 Passive Closure Devices
  • 5.2 By Application
    • 5.2.1 Femoral Arterial Access Procedures
    • 5.2.2 Radial Arterial Access Procedures
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Care Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Cardinal Health (Cordis)
    • 6.1.3 Cardiva Medical (Haemonetics)
    • 6.1.4 Medtronic PLC
    • 6.1.5 Merit Medical
    • 6.1.6 Teleflex Incorporated
    • 6.1.7 Terumo Corporation
    • 6.1.8 Otsuka Medical Devices Co. Ltd (Veryan Medical)
    • 6.1.9 Vivasure Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS